1. Dr. Hans-Joachim Schmoll. Experte für Darmkrebs. Biografie. 0
Dr. Hans-Joachim Schmoll, MD, explains his extensive career and contributions to cancer medicine. He is a professor and director of clinical oncology research in Germany....
▶⏸
2. Darmkrebsvorsorge. Welcher Test ist am effektivsten? Teil 1 von 2. Koloskopie. 1-1
Dr. Hans-Joachim Schmoll, MD, explains how colon cancer screening saves lives. He details the effectiveness of colonoscopy for early detection.
▶⏸
3. Staging von Darmkrebs. Molekulare Krebsklassifikation zur präzisen Behandlung von Tumoren. 2-1
Dr. Hans-Joachim Schmoll, MD, explains how molecular classification is transforming colon cancer treatment. He details the limitations of current staging systems for stage II and...
▶⏸
4. Darmkrebs-Stammzellen. Immuntherapie von Dickdarmkrebs. 3-1
Dr. Hans-Joachim Schmoll, MD, explains the critical role of cancer stem cells in treatment resistance and metastasis. He details how these cells evade chemotherapy and...
▶⏸
5. Präzise Chemotherapie von Darmkrebs. EGFR-, BRAF-, MEK-Inhibitoren. 4-1
Dr. Hans-Joachim Schmoll, MD, explains how to use mutations in EGFR, BRAF, and MEK pathways to select a personalized treatment plan. He details the efficacy...
▶⏸
6. Prognose Darmkrebs. Adaptive klinische Studien. Vorhersage des Ansprechens auf die Behandlung. 8-1
Dr. Hans-Joachim Schmoll, MD, explains how precision medicine and molecular tumor profiling are reshaping colon cancer prognosis. He details the shift from traditional staging to...
▶⏸
7. Die Qualität der Behandlung von Darmkrebs ist sehr unterschiedlich. 9-1
Dr. Hans-Joachim Schmoll, MD, explains how treatment quality varies globally. He details the critical role of multidisciplinary teams in creating optimal treatment plans.
▶⏸
8. Darmkrebsvorsorge. Welcher Test ist am effektivsten? Tumor-DNA-Tests aus Kot und Blut. Teil 2 von 2. 1-2
Dr. Hans-Joachim Schmoll, MD, explains how traditional fecal occult blood tests only detect intermediate or advanced stage cancers. He details the evolution to more sensitive...
▶⏸
9. Präzise Behandlung von Dickdarmkrebs. Das genetische Profil des Patienten ist wichtig. 2-2
Dr. Hans-Joachim Schmoll, MD, explains how a patient's own genetic profile is critical for treatment personalization. He details recent clinical trial data showing germline mutations...
▶⏸
10. Darmkrebs-Immuntherapie. Welche Patienten profitieren am meisten? 3-2
Dr. Hans-Joachim Schmoll, MD, explains how immunotherapy activates the body's immune system to attack tumors. He details that immune checkpoint inhibitors are highly effective for...
▶⏸
11. Behandlung von Darmkrebs mit HER2-Hemmern. Herceptin und Lapatinib (Tykerb). 4-2
Dr. Hans-Joachim Schmoll, MD, explains HER2 inhibitors for colon cancer treatment. He details how trastuzumab (Herceptin) and lapatinib (Tykerb) target HER2-positive tumors. This dual inhibition...
▶⏸
12. Vorhersage der Wirksamkeit der Capecitabin (Xeloda)-Therapie. Genexpression des DPD-Enzyms bei Dickdarmkrebs. 5-2
Dr. Hans-Joachim Schmoll, MD, explains how the DPD enzyme predicts treatment response. DPD gene expression in a colon cancer tumor is a strong biomarker for...
▶⏸
13. Flüssigbiopsie bei Darmkrebs. Präzise Diagnose und Behandlung. 8-2
Dr. Hans-Joachim Schmoll, MD, explains how liquid biopsy transforms cancer monitoring. This advanced technique analyzes tumor DNA and RNA from a simple blood draw. It...
▶⏸
14. Jeder Krebspatient muss vom Tumor Board evaluiert werden. Multidisziplinäres Team. 9-2
Dr. Hans-Joachim Schmoll, MD, explains the critical importance of a Multidisciplinary Team (MD T) or Tumor Board for every cancer patient. He details how this...
▶⏸
15. Behandlung von Dickdarmkrebs im Stadium 3. Capecitabin (Xeloda) und 5-Fluorouracil (5-FU). 5-1
Dr. Hans-Joachim Schmoll, MD, explains stage 3 colon cancer therapy. He details the critical role of optimal surgery and lymph node removal.
▶⏸
16. Chemotherapie des Rektumkarzinoms. Capecitabin (Xeloda) und Oxaliplatin 5-FU. Kontroversen. 5-3
Dr. Hans-Joachim Schmoll, MD, explains the role of chemotherapy in rectal cancer treatment. He details how chemotherapy and radiotherapy can sometimes eradicate tumors before surgery....
Dr. Hans-Joachim Schmoll, MD, explains advanced treatment options for stage 4 colon cancer with liver or lung metastases. He details how systemic chemotherapy can convert...
▶⏸
18. Darmkrebs-Chemotherapie bei älteren Menschen. Wählen Sie die Behandlung basierend auf Ihrer Fitness. 6
Dr. Hans-Joachim Schmoll, MD, explains how to choose chemotherapy for elderly patients. Over half of colorectal cancer cases are diagnosed in patients over 70. Treatment...
▶⏸
19. Rektumkarzinomtherapie ohne Operation. Zukunft der Darmkrebsbehandlung. 10
Dr. Hans-Joachim Schmoll, MD, explains how rectal cancer treatment is evolving. Chemotherapy and radiation can sometimes eradicate rectal tumors completely. This allows select patients to...
Verfeinern Sie Ihren Behandlungsplan bis zur Perfektion durch ein Gremium von 3 bis 10+ Top-Ärzten, die perfekt für Sie sind.
